Common yeast may worsen IBD symptoms in Crohn's disease
During the past decade the gut has experienced a renaissance as investigations focus on the role of the microbiome on human health. While most studies have focused on bacteria the dominant microbial...
View ArticleHealthcare Entrepreneurs Launch WeInfuse Set Sights on Improving Access to...
AUSTIN Texas March 8 2017 PRNewswire For persons living with multiple sclerosis Crohn's Disease rheumatoid arthritis or Lupus easy access to their lifechanging medications and treatments is critical to...
View ArticleIBD Genetic differences in Crohn's disease susceptibility and outcome
A new genomewide association study GWAS has been conducted to discover genetic contributions that can explain disease prognosis in Crohn's disease. This understudied area deserves attention for...
View ArticleAevi Genomic Medicine Reports Fourth Quarter and Full Year 2016 Financial...
PHILADELPHIA PA Marketwired 030917 Aevi Genomic Medicine Inc. NASDAQ GNMX Topline data from SAGA Phase 23 trial of AEVI001 in adolescents with mGluR ADHD to be announced by end of Q1 Robust pipeline...
View ArticleNew indicators to aid Crohn's disease diagnosis and treatment
Arizona State University The diagnosis understanding and management of Crohn's disease may have just received a helping hand from a joint ASU Biodesign Institute and Mayo Clinic study aimed at...
View ArticleCrohn's & Colitis Foundation and AGA announce conference partnership
American Gastroenterological Association The Crohn's & Colitis Foundation and the American Gastroenterological Association announced today that they are partnering to cosponsor the firstever...
View ArticleLarry Smarr Drives Innovation as Experimental Patient of the Future
In the years since he basically selfdiagnosed his own Crohns Disease before he had symptoms Larry Smarr has served as a pioneer in the digital transformation of medicine and as an n of 1 experimental...
View ArticleProtagonist Therapeutics to Present at the Oppenheimer & Co. Healthcare...
MILPITAS Calif. March 9 2017 PRNewswire Protagonist Therapeutics Inc. NASDAQ PTGX today announced that Dinesh V. Patel Ph.D. the company's President and Chief Executive Officer will provide a corporate...
View ArticleCommon Yeast May Worsen IBD Symptoms in Crohns Disease
Clinical trials will need to be done determine whether yeast exacerbates IBD in people as it does in mice
View ArticleGalapagos Release New Phase 2 Studies With Filgotinib In Small Bowel And...
Life Sciences Jobs ...
View ArticleTiGenix reports positive topline results from Phase III trial of Cx601 for...
Belgiumbased biopharmaceutical company TiGenix has reported positive topline week 104 results from the Phase III clinical trial ADMIRECD of Cx601 for the treatment of complex perianal fistulas in...
View ArticleNew Phase 2 studies with filgotinib in small bowel and fistulizing Crohn's...
Mechelen Belgium; 10 March 2017 Galapagos NV Euronext & NASDAQ GLPG announces two new Phase 2 studies investigating Âfilgotinib in small bowel Crohn's disease as well as in fistulizing Crohn's...
View ArticleGalapagos Release New Phase II Studies With Filgotinib In Small Bowel And...
Life Sciences Jobs ...
View ArticleMaladie de CROHN Bientt un test de diagnostic sanguin JCC
Pour aider les patients atteints de la maladie de Crohn il faudrait pouvoir développer un nouveau test de diagnostic précoce et précis puis une thérapie...
View ArticlePositive results for infliximab biosimilar in Crohns disease
Results of a phase III study of Celltrions infliximab biosimilar Remsima; CTP13 indicate that the safety and efficacy of CTP13 in patients with moderatetosevere Crohns disease is comparable to those...
View ArticleRedHill Biopharma Ltd RDHL Medical Equipment Deals and Alliances Profile...
SummaryRedHill Biopharma Ltd RedHill is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs for the treatment of inflammatory and gastrointestinal...
View ArticleTxCell SA TXCL Financial and Strategic SWOT Analysis Review Updated 13012017...
SummaryTxcell SA Txcell is a biotechnology company that develops and innovates cellbased immunotherapy utilizing antigen specific regulatory Tcells with focus on chronic inflammatory and autoimmune...
View ArticleAbbVie Inc ABBV Medical Equipment Deals and Alliances Profile Updated...
SummaryAbbVie Inc AbbVie is a researchbased biopharmaceutical company that carries out the research development manufacture and commercialization of advanced therapies to treat complex and serious...
View ArticleImmune Pharmaceuticals Granted Additional Time to Comply with Nasdaq Listing...
NEW YORK March 13 2017 PRNewswire Immune Pharmaceuticals Inc. Nasdaq IMNP "Immune" or the "Company" announced today that following a hearing on March 9 2017 where the Company presented its plan to...
View ArticleProtalex Significantly Strengthens Global Intellectual Property Portfolio for...
Granted Six Key International Patents Protecting and Expanding Use for PRTX100 Protalex Inc. OTCQBPRTX a clinicalstage biopharmaceutical company announces that the Company has been granted several key...
View Article